Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types

Abstract Siglec-9, a cell surface transmembrane receptor mainly expressed on B cells, CD56+ NK cells, and CD4+ and CD8+ T…